Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2007-01-15 (19 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: YVETOT (76190), Seine-Maritime
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE BRUNEL : revenue, balance sheet and financial ratios
PHARMACIE BRUNEL is a French company
founded 19 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in YVETOT (76190),
this company of category PME
shows in 2021 a revenue of 4.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE BRUNEL (SIREN 494028616)
Indicator
2025
2024
2023
2022
2021
Revenue
N/C
N/C
N/C
N/C
4 363 230 €
Net income
428 298 €
349 885 €
417 405 €
467 170 €
405 367 €
EBITDA
N/C
N/C
N/C
N/C
591 063 €
Net margin
N/C
N/C
N/C
N/C
9.3%
Revenue and income statement
In 2025, PHARMACIE BRUNEL generates positive net income of 428 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2025: 405 k€ -> 428 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
428 298 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 80%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
80.233%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
46.875%
Solvency indicators evolution PHARMACIE BRUNEL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2022
2023
2024
2025
Debt ratio
382.109
223.557
155.355
113.23
80.233
Financial autonomy
17.526
26.395
33.806
39.88
46.875
Repayment capacity
7.167
None
None
None
None
Cash flow / Revenue
10.384%
None%
None%
None%
None%
Sector positioning
Debt ratio
80.232025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average-12 pts over 3 years
In 2025, the debt ratio of PHARMACIE BRUNEL (80.23) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
46.88%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average+10 pts over 3 years
In 2025, the financial autonomy of PHARMACIE BRUNEL (46.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE BRUNEL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2022
2023
2024
2025
Operating WCR
443 348 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
32
0
0
0
0
Customer payment term (days)
8
0
0
0
0
Supplier payment term (days)
53
0
0
0
0
Positioning of PHARMACIE BRUNEL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE BRUNEL is estimated at
6 803 564 €
(range 4 616 931€ - 10 675 729€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
4616k€6803k€10675k€
6 803 564 €Range: 4 616 931€ - 10 675 729€
NAF 5 année 2025
Valuation method used
Net Income Multiple
428 298 €
×
15.9x
=6 803 565 €
Range: 4 616 931€ - 10 675 730€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE BRUNEL with other companies in the same sector:
The revenue of PHARMACIE BRUNEL in 2021 is 4.4 M€.
Is PHARMACIE BRUNEL profitable?
Yes, PHARMACIE BRUNEL generated a net profit of 428 k€ in 2025.
Where is the headquarters of PHARMACIE BRUNEL ?
The headquarters of PHARMACIE BRUNEL is located in YVETOT (76190), in the department Seine-Maritime.
Where to find the tax return of PHARMACIE BRUNEL ?
The tax return of PHARMACIE BRUNEL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE BRUNEL operate?
PHARMACIE BRUNEL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart